Trial gout drug shows promise2nd June 2011
A new drug currently involved in clinical trials has shown promise for the treatment of patients with gout.
The particularly painful form of inflammatory arthritis that develops when a substance called urate (uric acid) builds up and forms crystals in the joints. BCX4208 is an oral therapy designed to help lower levels of uric acid in the blood. According to the results of two phase-II studies, the drug can help to bring uric acid below the desired level when taken alongside the existing gout therapy allopurinol.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Trial gout drug shows promise
Author: Mark Nicholls
Article Id: 18654
Date Added: 2nd Jun 2011